Legend Biotech
LEGN
15.25
-0.85
-5.28%
Legend Biotech
US · LEGN
#2374 by market cap
Listed 2020
15.25
-0.85
-5.28%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About Legend Biotech
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Bridgewater, NJ.
- Founded
- 2015
- CEO
- Dr. Ying Huang, PhD
- Employees
- 2,900
- Headquarters
- Bridgewater, New Jersey, United States of America
- Fiscal year end
- 12-31
- Website
- legendbiotech.com
Company profile
- Exchange
- US
- Symbol
- LEGN
- Market-cap rank
- #2374
- Listing date
- 2020-06-05
- Market cap
- 2.96B
- Float cap
- 1.39B
- Shares out
- 193.97M
- Float shares
- 91.01M
Sectors & themes
Quote time 2026-11-20 20:02:40 · For reference only, not investment advice and not tailored to your situation.
Legend Biotech discussion 0 comments